ARCHIVES

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer

May 1, 1981

Mortality, Survival Still Improving for Whites, Remain Static Or Decline For Blacks; Largest Survival Increase For Whites In history Of SEER Program

June 2, 1989

In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review

November 3, 1978

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977

Treatment Doesn’t Always Follow Recommendations

February 25, 2005